Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).

Recruiting now · Phase 2

Conditions studied: Cervical Cancers

In brief

This is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.

Key facts

Study ID

NCT07022470

Run by

Stanford University

People needed

41

Starts

2025-06-03

Expected to finish

2028-06-01

Last updated by the study team

2026-06-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically documented malignancy of the cervix and planned to receive brachytherapy as part of definitive treatment.
• ECOG performance status of 0-2
• Age ≥ 18 years old.
• Ability to understand and the willingness to provide written informed consent.

You may not qualify if…

• Contraindication to receiving radiotherapy as determined by treating radiation oncologist.
• Contraindication to receiving MRI.
• Prior radiation to the pelvis > 3 months ago
• Age < 18 years old.
• Pregnant or breast-feeding

Where it is running

• Stanford University — Palo Alto, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.